Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis.
about
My approach to the treatment of sclerodermaDistribution of late gadolinium enhancement in various types of cardiomyopathies: Significance in differential diagnosis, clinical features and prognosisTrends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studiesA critical view on cardiovascular risk in systemic sclerosis.Cardiac arrhythmias and conduction defects in systemic sclerosisPoor survival in patients with scleroderma and pulmonary hypertension due to heart failure with preserved ejection fractionSystemic sclerosis and the heart: current diagnosis and management.Cardiac manifestations in systemic sclerosis.Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study.Characteristics and clinical relevance of late gadolinium enhancement in cardiac magnetic resonance in patients with systemic sclerosis.Prevalence, prognosis, and factors associated with left ventricular diastolic dysfunction in systemic sclerosis.The primary care physician in the early diagnosis of systemic sclerosis: the cornerstone of recognition and hope.Recognizing systemic sclerosis: comparative analysis of various sets of classification criteria.A Marked Response to Immunosuppressive Intervention for Abruptly Occurring Cardiac Complications in a Case of Juvenile Systemic Sclerosis Overlapped with Dermatomyositis.Registries in systemic sclerosis: a worldwide experience.The impact of cardiopulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies.Imaging modalities for the diagnosis of pulmonary hypertension in systemic sclerosis.N-TproBNP as biomarker in systemic sclerosis.Is there evidence for vasculitis in systemic sclerosis?Risk factors for severity and manifestations in systemic sclerosis and prediction of disease course.Consensus best practice pathway of the UK Systemic Sclerosis Study group: management of cardiac disease in systemic sclerosis.Multimodality imaging in restrictive cardiomyopathies: an EACVI expert consensus document: In collaboration with the 'Working Group on myocardial and pericardial diseases' of the European Society of Cardiology Endorsed by the Indian Academy of EchocPrimary myocardial disease in scleroderma-a comprehensive review of the literature to inform the UK Systemic Sclerosis Study Group cardiac working group.Extrahepatic Manifestations of Primary Biliary Cholangitis.Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners.Electrocardiography in 110 patients with systemic sclerosis: a cross-sectional comparison with population-based controls.Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study.A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study.Prevalence and risk factors for left ventricular diastolic dysfunction in a scleroderma cohort.Cardiac involvement in systemic sclerosis: differences between clinical subsets and influence on survival.Left ventricular systolic dysfunction in two patients with ankylosing spondylitis: What is the role of corticosteroids?Autoimmune myocarditis in systemic sclerosis: an unusual form of scleroderma heart disease presentation.Myopathies related to systemic sclerosis: a case-control study of associated clinical and immunological features.Prediction of pulmonary hypertension related to systemic sclerosis by an index based on simple clinical observations.Myopathy is a poor prognostic feature in systemic sclerosis: results from the Canadian Scleroderma Research Group (CSRG) cohort.Cardiac biomarkers in systemic sclerosis: contribution of high-sensitivity cardiac troponin in addition to N-terminal pro-brain natriuretic peptide.Ten years EULAR Scleroderma Research and Trials (EUSTAR): what has been achieved?Cardiac involvement in undifferentiated connective tissue disease at risk for systemic sclerosis (otherwise referred to as very early-early systemic sclerosis): a TDI study.Determinants of mortality in systemic sclerosis: a focused review.Points to consider when doing a trial primarily involving the heart.
P2860
Q24618843-1C42E322-3BF7-4CFE-A26C-19E4DAA8D782Q26864740-AEDB7259-590A-4C10-803A-3C774200AC60Q26864958-B0499CA2-A37F-4300-89E6-DCF775238170Q30249024-1612F2BD-F51A-4CC0-9259-ED023DA3A923Q33783945-BEA7A23A-C7C6-47ED-803B-E07D6B513D13Q33788474-343CC48C-20C4-44C9-A46F-60A2EDE11D19Q34012584-7CD31806-6D90-4ED6-AB3D-86B6218B94F5Q34251904-2E965073-2372-4603-9D7F-25F3EC723A79Q36153763-B23BD07B-64F3-42D8-91B9-9A40EEECB23DQ36289875-C80254D2-6DBC-4C02-A009-62EA63A0C5F3Q36426529-A112786D-9BA5-4503-AC8A-7C5DD88E7A27Q37413166-FB682B2C-554A-4EAB-8A4E-94EBE98697ADQ37590671-4E90B602-01C8-438B-A897-833748EC3C5DQ37683545-40D58048-7295-40E8-A322-E5B9B6F644FDQ37819494-AF8B13F3-826E-43BF-A778-04F23264DA8BQ37973712-4398CD94-DD99-486D-BD48-9706972F59ABQ37981825-2F117498-1050-4063-8BA8-CE792E0ACECEQ38016375-4665EA8F-5932-44B5-A1CD-704D35FE4A7CQ38052089-DC7A2968-A9C1-4CCF-A536-7E7B4C37F5AAQ38630663-BF46A453-6231-4093-BFB8-4D72EFDBF762Q38761664-4C41A25D-F51F-4B54-BCB3-17889E23D766Q38782767-C2135E7F-8446-4CD2-88AA-B9D2B0E7A2E9Q39035482-173ADEC4-13B6-49CE-94DD-4E3EA7882B66Q39177903-B61076CF-EF51-4D08-A3DB-66A758293488Q39322066-64FF54F9-842B-4D9A-843F-AB50BC431068Q40162142-2BDBCA49-E2ED-4C23-8844-65A08531FE61Q40218254-3EE10468-09EB-4D65-A1B8-4CB7A632EA15Q40230825-9C2F7D88-DD3C-416A-892F-BC7F6635A06BQ40578596-2ECD4A66-50A6-4EED-8E2D-1AC69AA5D9D9Q41189863-0D5759C4-638B-476F-9267-34B909B869E2Q42325624-E3936376-2740-49FE-8AC0-AA8DF4C8A36EQ42341882-36268151-310E-45C8-8254-5F7E5D60B7D6Q42931182-7743ADCB-BF8F-42D0-90F9-7D69A7A55B5FQ44262313-66EE7101-A580-4E22-93A9-E19C48B9FA8CQ44628402-B4E9B39A-7B19-4D6C-8B54-E4A33108566CQ45112554-D4676120-330E-455C-841C-35CA9AE8EF16Q45412349-58475BBF-25BE-4515-9393-4C3AE5E74390Q47615498-7DC7D17B-5A98-41A0-9CD8-C6C7F0778050Q47633128-FC3F51E8-D109-4D8E-8457-06D91EF81F94Q47835792-EE456C10-B77C-48E8-9836-1AB6F74C8708
P2860
Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Prevalence and factors associa ...... ients with systemic sclerosis.
@en
Prevalence and factors associa ...... derma Trial and Research group
@nl
type
label
Prevalence and factors associa ...... ients with systemic sclerosis.
@en
Prevalence and factors associa ...... derma Trial and Research group
@nl
prefLabel
Prevalence and factors associa ...... ients with systemic sclerosis.
@en
Prevalence and factors associa ...... derma Trial and Research group
@nl
P2093
P50
P356
P1476
Prevalence and factors associa ...... ients with systemic sclerosis.
@en
P2093
B Stamenkovic
E Hachulla
P304
P356
10.1136/ARD.2008.103382
P407
P577
2010-01-01T00:00:00Z